Association of +45(T (6) Esteghamati, Alireza a Mansournia, Nasrin a Nakhjavani, Manouchehr a Mansournia, Mohammad Ali a,b Nikzamir, Abdolrahim c Abbasi, Mehrshad a,d a TEHRAN UNIVERSITY OF MEDICAL SCIENCES (Iran) b AJA UNIVERSITY OF MEDICAL SCIENCES (Iran) c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES (Iran) d TEHRAN UNIVERSITY OF MEDICAL SCIENCES (Iran)

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 3791-3797

Author keywords

Adiponectin gene; Coronary artery disease; Polymorphism; Single nucleotide; Type 2 diabetes

Indexed keywords

GLYCINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THREONINE; TRIACYLGLYCEROL; ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

ADIPONECTIN GENE; ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; IRAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUTATOR GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; POPULATION GENETICS;

ADIPONECTIN; ADULT; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; IRAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84861811217     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1156-9     Document Type: Article

References (62)

1. Stamler J, Vaccaro O, Neaton JD et al (1993) The Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444
2. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: The Framingham Study. JAMA 241:2035-2038
3. Okamoto Y, Arita Y, Nishida M et al (2000) An adipocytederived plasma protein, adiponectin, adheres to injured vascular walls (Abstract). Horm Metab Res 32:47A
4. Goldstein BJ, Scalia RG, Ma XL (2009) Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 6(1):27-35
5. Schnabel R, Messow CM, Lubos E et al (2008) Association of adiponectin with adverse outcome in coronary artery disease patients: Results from the AtheroGene study. Eur Heart J 29(5):649-657
6. Sattar N, Wannamethee G, Sarwar N et al (2006) Adiponectin and coronary heart disease: A prospective study and meta-analysis. Circulation 114(7):623-629
7. Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
8. Schwarz PE, Towers GW, Fischer S et al (2006) Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 29:1645-1650
9. Thamer C, Haap M, Heller E et al (2006) Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes. Horm Metab Res 38:178-182
10. Qiao L, MacLean PS et al (2005) C/EBPa regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54:1744-1754
11. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ et al (2000) The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280:E827-E847
12. Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703
13. Maeda K, Okubo K, Shimomura I et al (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289
14. Nakano Y, Tobe T, Choi-Miura NH et al (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 120:803-812
15. Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinaemia. J Clin Endocrinol Metab 86:1930-1935
16. Acobellis G, Pistilli D, Gucciardo M et al (2005) Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 29(6):251-255
17. Comuzzie AG, Funahashi T, Sonnenberg G et al (2001) The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86:4321-4325
18. Civitarese AE, Jenkinson CP, Richardson D et al (2004) Adiponectin receptors gene expression and insulin sensitivity in nondiabetic Mexican Americans with or without a family history of type 2 diabetes. Diabetologia 47:816-820
19. Stefan N, Vozarova B, Funahashi T et al (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51:1884-1888
20. Funahashi T, Nakamura T, Shimomura I, Maeda et al (1999) Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38:202-206
21. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
22. Ziccardi P, Nappo F, Giugliano G et al (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804-809
23. Kubota N, Terauchi Y, Yamauchi T et al (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866
24. Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
25. Arita Y, Kihar S, Funahashi T et al (1998) Anovel adipocytederived factor, adiponectin, is decreased in obeity and coronary artery disease. Int J Obes 22:S40-S119
26. Kojima S, Funahashi T, Sakamoto T et al (2003) The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 89(6):667
27. Kumada M, Kihara S, Sumitsuji S et al (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23(1):85-89
28. Zoccali C, Mallamaci F, Tripepi G et al (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13(1):134-141
29. Pischon T, Girman CJ, Hotamisligil GS et al (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291(14):1730-1737
30. Lindsay RS, Funahashi T, Hanson RL et al (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58
31. Spranger J, Kroke A, Mohlig M et al (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226-228
32. Snehalatha C, Mukesh B, Simon M et al (2003) Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26:3226-3229
33. Duncan BB, Schmidt MI, Pankow JS et al (2004) Adiponectin and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes 53:2473-2478
34. Frystyk J, Berne C, Berglund L et al (2007) Serum adiponectin is a predictor of coronary heart disease: A populationbased 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92:571-576
35. Sattar N, Wannamethee G, Sarwar N et al (2006) Adiponectin and coronary heart disease: A prospective study and meta-analysis. Circulation 114:623-629
36. Takahashi M, Arita Y, Yamagata K et al (2000) Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 24:861-868
37. Vionnet N, Hani EH, Dupont S et al (2000) Genome-wide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-24. Am J Hum Genet 67:1470-1480
38. Hara K, Boutin P, Mori Y et al (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536-540
39. Vasseur F, Helbecque N, Dina C et al (2002) Single-nucleotide polymorphism haplotypes in both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607-2614
40. Gu HF, Abulaiti A, Östenson C et al (2004) Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 53(Suppl 1):S31-S35
41. Stumvoll M, Tschritter O, Fritsche A et al (2002) Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity. Interaction with family history of type 2 diabetes. Diabetes 51:37-41
42. Lacquemant C, Froguel P, Lobbens S et al (2004) The adiponectin gene SNP?45 is associated with coronary artery disease in type 2 (non-insulin- dependent) diabetes mellitus. Diabet Med 21:776-781
43. Lee YY, Lee NS, Cho YM et al (2003) Genetic association of adiponectin polymorphisms with risk of type 2 diabetes mellitus. J Korean Diabetes Assoc 27:438-448
44. Nakamura Y, Shimada K, Fukuda D et al (2004) Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90:528-533
45. Filippi E, Sentinelli F, Romeo S et al (2005) The adiponectin gene SNP?276G[T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age\or = 50 years). J Mol Med 83(9):711-719
46. Liu F, He Z, Deng S (2011) Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population. Mol Biol Rep 38(3):1983-1988
47. Qi L, Doria A, Manson JE et al (2006) Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes 55(5):1512-1516
48. Kim SH, Kang ES, Hur KY et al (2008) Adiponectin gene polymorphism 45T[G is associated with carotid artery plaques in patients with type 2 diabetes mellitus. Metabolism 57:274-279
49. Zhang N, Shi Y-H, Hao C-F (2008) Association of C45G15G(T/G) and C276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women. Eur J Endocrinol 158:255-260
50. Takahashi M, Arita Y, Yamagata K et al (2000) Genomic structure and mutations in adiposespecific gene, adiponectin. Int J Obesity 24:861-868
51. Filippi E, Sentinelli F, Trischitta V et al (2004) Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 12:199-205
52. Al-Daghri NM, Al-Attas OS et al (2011) Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes. Mol Biol Rep. doi:10.1007/s11033-010-0484-5
53. Bacci S, Menzaghi C, Ercolino T, Ma X, Rauseo A, Salvemini L et al (2004) The ?276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 27(8):2015-2020
54. Qi L, Li T, Rimm E, Zhang C et al (2004) The ?276 polymorphism of the APM1 gene, plasma diponectin concentration, and cardiovascular risk in diabetic men. Diabetes 54(5):1607-1610
55. Jang Y, Lee JH, Chae JS et al (2005) Association of the 276G ? T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 82:760-767
56. Pischon T, Pai JK, Manson JE et al (2007) Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women. Obesity (Silver Spring) 15(8):2051-2060
57. Jung CH, Rhee EJ, Kim SY et al (2006) Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases. Endocr J Oct 53(5):671-677
58. Menzaghi C, Ercolino T, Di Paola R et al (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51:2306-2312
59. Fumeron F, Aubert R, Siddiq A et al (2004) Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: The epidemiologic data Jung on the insulin resistance syndrome prospective study. Diabetes 53(4):1150-1157
60. Halvatsiotis I, Tsiotra PC, Ikonomidis I et al (2010) Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes. Cardiovasc Diabetol 9:10. doi:10.1186/1475-2840-9-10
61. Heid IM, Wagner SA, Gohlke H et al (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55(2):375-384
62. Ferrarezi DA, Cheurfa N, Reis AF et al (2006) Adiponectin gene and cardiovascular risk in Type 2 diabetic patients: A review of evidences. Arq Bras Endocrinol Metabol 51(2):153-159